SKSoyoun Kim

Soyoun Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Soyoun Kim has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Selection of DNA Aptamers Against Botulinum Neurotoxin E for Development of Fluorescent Aptasensor

    by Shuo Ren, Hye‐Soo Shin, Vinayakumar Gedi, Pooja Dua, Dong‐Ki Lee, Soyoun Kim

    Botulinum neurotoxins (BoNTs) produced by Clostridium botulinum are the deadliest toxins known to mankind with a potential of possible bioterrorism agents. Due to the high‐potential harm of these toxins, a sensitive and real‐time monitoring capable detection systems are required for the early stage detection. In this study, a novel sol–gel‐based SELEX was used to isolate single‐stranded nucleic acids (ssDNA) aptamers against purified BoNT type E toxoid (BoNTE) using a chemically synthesized random N40 ssDNA library. The bound aptamer sequences after five rounds were analyzed using next‐generation sequencing and the resulted high‐frequency aptamers were characterized using biolayer interferometry. Among the tested, aptamer BT5.6 showed low nanomolar binding affinity (KD, 53.3 nM) toward BoNTE. As a proof of concept, the aptamer was utilized in a graphene oxide‐based detection platform. In summary, we screened and identified a ssDNA aptamer with high affinity toward BoNTE, which, we believe can be used for development of sensitive detection systems.


  • Multiplex Human Immunodeficiency Virus 1/2 and Hepatitis C Virus Antibodies Simultaneous Detection Using Three‐Dimensional Sol–Gel Nanoporous Capturing Technology

    by Kyung Hoon Hwang, Yeona Ki, Young Mi Lee, Jin Ah Lee, In Kyoung Choi, Jun Sung Park, Jinhong Kim, Jasmine Kang, Yury Kukushkin, Eun Jee Oh, et al.

    The sol–gel nanoporous capturing technology represents a powerful approach where the sol–gel matrix constrains the motion of the encapsulated biomolecules (proteins, peptides, chemicals, antibodies, nucleotides, etc.) without physical adsorption or any modifications. This technology can be applied to multiplex immunoassay platform because several disease markers can be immobilized and tested at once. In this study, we have tested several thousand specimens using Hi3‐1 Multiplex human immunodeficiency virus (HIV) 1/2 and hepatitis C virus (HCV) antibody detection kit at two clinical trials institutes. These results showed a highest sensitivity (100%, n = 500 HIV‐positive specimens and n = 400 HCV‐positive) and specificity (99.99% for HIV and 99.83% for HCV, n = 7706 negative specimens) by using Hi3‐1 kit, which screens HIV1/2 and HCV antibodies simultaneously. Finally, we suggested that our screening technology was successfully utilized as a multiplex HIV and HCV diagnostic tool for blood bank screening.


  • Open Access

    Cell-SELEX Based Identification of an RNA Aptamer for Escherichia coli and Its Use in Various Detection Formats

    by Pooja Dua, Shuo Ren, Sang Wook Lee, Joon-Ki Kim, Hye-Su Shin, Ok-Chan Jeong, Soyoun Kim, Dong-Ki Lee

    Pooja Dua, Shuo Ren, Sang Wook Lee, Joon-Ki Kim, Hye-su Shin, OK-Chan Jeong, Soyoun Kim, and Dong-Ki Lee. Mol. Cells 2016;39:807-13. https://doi.org/10.14348/molcells.2016.0167


  • Open Access

    Understanding the molecular aspects of oriental obesity pattern differentiation using DNA microarray

    by Sun Woo Hong, Jae-Wook Yoo, Shambhunath Bose, Jung-Hyun Park, Kyungsun Han, Soyoun Kim, Chi-Yeon Lim, Hojun Kim, Dong-Ki Lee

    Human constitution, the fundamental basis of oriental medicine, is categorized into different patterns for a particular disease according to the physical, physiological, and clinical characteristics of the individuals. Obesity, a condition of metabolic disorder, is classified according to six patterns in oriental medicine, as follows: spleen deficiency syndrome, phlegm fluid syndrome, yang deficiency syndrome (YDS), food accumulation syndrome (FAS), liver depression syndrome (LDS), and blood stasis syndrome. In oriental medicine, identification of the disease pattern for individual obese patients is performed on the basis of differentiation in obesity syndrome index and, accordingly, personalized treatment is provided to the patients. The aim of the current study was to understand the obesity patterns in oriental medicine from the genomic point of view via determining the gene expression signature of obese patients using peripheral blood mononuclear cells as the samples. The study was conducted in 23 South Korean obese subjects (19 female and four male) with BMI ≥25 kg/m2. Identification of oriental obesity pattern was based on the software-guided evaluation of the responses of the subjects to a questionnaire developed by the Korean Institute of Oriental Medicine. The expression profiles of genes were determined using DNA microarray and the level of transcription of genes of interest was further evaluated using quantitative real-time PCR (qRT-PCR). Gene clustering analysis of the microarray data from the FAS, LDS, and YDS subjects exhibited disease pattern-specific upregulation of expression of several genes in a particular cluster. Further analysis of transcription of selected genes using qRT-PCR led to identification of specific genes, including prostaglandin endoperoxide synthase 2, G0/G1 switch 2, carcinoembryonic antigen-related cell adhesion molecule 3, cystein-serine-rich nuclear protein 1, and interleukin 8 receptor, alpha which were highly expressed in LDS obesity constitution. Our current study can be considered as a valuable contribution to the understanding of possible explanation for obesity pattern differentiation in oriental medicine. Further studies can address a novel possibility that the genomic and oriental empirical approaches can be combined and implemented in systematic and synergistic development of personalized medicine. This clinical trial was registered in Clinical Research Information Service of Korea National Institute of Health ( https://cris.nih.go.kr/cris/index.jsp ). Registration number: KCT0000387


  • Biomimetic sensor design

    by Ju Hun Lee, Hyo-Eon Jin, Malav S. Desai, Shuo Ren, Soyoun Kim, Seung-Wuk Lee

    Detection of desired target chemicals in a sensitive and selective manner is critically important to protect human health, environment and national security.


  • ALPPL2 Aptamer-Mediated Targeted Delivery of 5-Fluoro-2′-Deoxyuridine to Pancreatic Cancer

    by Pooja Dua, Sajeesh S, Soyoun Kim, Dong-Ki Lee

    Nucleoside analogues are the most promising drugs for the treatment of pancreatic cancer to date. However, their use is often limited due to toxic side effects. Aptamer-mediated targeted delivery of these drugs to cancer cells could maximize their effectiveness and concomitantly minimize the toxic side effects by reducing uptake into normal cells. Previously, we identified a pancreatic cancer-specific, nuclease-resistant RNA aptamer, SQ2, which binds to alkaline phosphatase placental-like 2 (ALPPL2), a putative biomarker for pancreatic cancer. In this study, we demonstrate that the aptamer can be internalized into pancreatic cancer cells and can thus be used for the targeted delivery of therapeutics. Using the aptamer as a ligand, we established that glycophosphatidylinositol-anchored ALPPL2 is internalized by the cells through clathrin-independent and caveolae-dependent or dynamin-mediated cell-type-dependent pathways. Finally, we show that SQ2 can deliver nucleoside drug 5-fluoro-2′-deoxyuridine specifically to ALPPL2-expressing pancreatic cancer cells, inhibiting cell proliferation.


  • Open Access

    A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer

    by Sang Wook Lee, Kazuo Hosokawa, Soyoun Kim, Ok Chan Jeong, Hans Lilja, Thomas Laurell, Mizuo Maeda

    Levels of total human kallikrein 2 (hK2), a protein involved the pathology of prostate cancer (PCa), could be used as a biomarker to aid in the diagnosis of this disease. In this study, we report on a porous silicon antibody immunoassay platform for the detection of serum levels of total hK2. The surface of porous silicon has a 3-dimensional macro- and nanoporous structure, which offers a large binding capacity for capturing probe molecules. The tailored pore size of the porous silicon also allows efficient immobilization of antibodies by surface adsorption, and does not require chemical immobilization. Monoclonal hK2 capture antibody (6B7) was dispensed onto P-Si chip using a piezoelectric dispenser. In total 13 × 13 arrays (169 spots) were spotted on the chip with its single spot volume of 300 pL. For an optimization of capture antibody condition, we firstly performed an immunoassay of the P-Si microarray under a titration series of hK2 in pure buffer (PBS) at three different antibody densities (75, 100 and 145 µg/mL). The best performance of the microarray platform was seen at 100 µg/mL of the capture antibody concentration (LOD was 100 fg/mL). The platform then was subsequently evaluated for a titration series of serum-spiked hK2 samples. The developed platform utilizes only 15 µL of serum per test and the total assay time is about 3 h, including immobilization of the capture antibody. The detection limit of the hK2 assay was 100 fg/mL in PBS buffer and 1 pg/mL in serum with a dynamic range of 106 (10−4 to 102 ng/mL).


  • Label-free Detection of the Transcription Initiation Factor Assembly and Specific Inhibition by Aptamers

    by Shuo Ren, Yuanyuan Jiang, Hye Rim Yoon, Sun Woo Hong, Donghyuk Shin, Sangho Lee, Dong-Ki Lee, Moonsoo M. Jin, Irene M. Min, Soyoun Kim


  • A cross-contamination-free SELEX platform for a multi-target selection strategy

    by SangWook Lee, Jeehye Kang, Shuo Ren, Thomas Laurell, Soyoun Kim, Ok Chan Jeong